“Name another company, any exchange, that would be selling something better than a cancer cure, covid inhibitor and neurological treatment.”
But they don’t actually have that. I realize many hope they do, some may believe they do…but let’s face it…even in the OTC where hope and dreams spring eternal it’s not like it’s tearing things up here.
The hype, the narrative, the “story”…will have little to no impact on the dynamics of the uplist offering.
I guarantee that the only thing the underwriter is really looking at are the company financials as they exist today, and the volume and price action of the stock.
Just how it is.
News 
Market Data 
Discover 
AI
